Starving Cancer Could Lead To New Treatments

An important supply route utilized by cancer cells to obtain nutrients has been identified and could be the key to implementing treatments that prevent tumor growth, according to a new study conducted by Australian National University.

By blocking the entry point through which cancerous cells obtain the amino acid glutamine, researchers were able to stop the cells from growing almost completely.

"This is likely to work in a wide range of cancers, because it is a very common mechanism in cancer cells," said Professor Stefan Bröer, lead researcher of the study. "Better still, this should lead to chemotherapy with much less serious side-effects, as normal cells do not use glutamine as a building material.”

Bröer also said that important white blood cells, which today’s treatment methods can harm, could be spared to help avoid the hair loss caused by chemotherapy.

Cures for cancer

Along with lymphoma, 916 different types of cancers have been identified and each requires its own unique treatment. These treatments can become less effective as cancers advance and develop resistance to chemotherapy.

Researchers now believe that new approaches to battling cancer can be implemented because restricting the glutamine transport system is an external technique that would make it difficult for cancer cells to combat.

Early results are promising, as Dr. Bröer and the team claimed that cell growth diminished by 96 percent after starving the cancer cells of the nutrients they needed to continue growing.

Source: EurekAlert!

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap